16 new COVID-19 cases added to Ilocos region's weekly tally | Inquirer ºÚÁÏÉç

ºÚÁÏÉç

16 new COVID-19 cases added to Ilocos region’s weekly tally

/ 05:22 PM June 07, 2022

DOH COVID-19 tracker: Active cases dip below 5,000-mark as of May 4

Test tube of the sample, positive for new coronavirus. File Photo

LAOAG CITY, Ilocos Norte—At least 16 more cases were added to the COVID-19 tally in the Ilocos region from May 29 to June 1, the regional Department of Health said on Tuesday, June 7. The new cases were 54 percent lower than those reported the week before, with 35 new patients, said the DOH. The daily average number of COVID-19 cases dipped to two compared with five in the previous week, said the DOH. Of the active cases, two were admitted to hospital facilities for treatment after being tagged as severe and critical. Data also showed that at least 46, or 20 percent of the 230 ICU (intensive care unit) beds dedicated to COVID-19 patients are in use. At least 166, or 11 percent of the 1,536 non-ICU beds, are occupied. The DOH also verified 152 deaths due to COVID-19 in the past week.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

For more news about the novel coronavirus click
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this

EDITORS' PICK
cebudailynews
entertainment
business
technology
sports
www
TAGS: COVID-19

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2025 ºÚÁÏÉç | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.